Fill in the form below
Download the sample attendee list from 2024
Advanced Therapies EuropeAdvanced Therapies EuropeAdvanced Therapies EuropeThis workshop covers innovations in standardised manufacturing processes for cell and gene therapies. Attendees will learn how to reduce costs, improve efficiency, and increase global access to CAR T and AAV-based therapies.
All #ATE24 workshops are FREE to attend, simply sign up via the form below.
Date & Time: 12th September 12.30 – 13.30
This workshop explores automation, digitisation, and global ecosystem integration in cell and gene therapy. Addressing manufacturing challenges, experts discuss strategies for scalable, resilient processes and efficient logistics in the industry.
All #ATE24 workshops are FREE to attend, simply sign up via the form below.
Date & Time: 12th September 12.30 – 13.30
This workshop will address challenges in iPSC-derived cell therapy, including GMP line access, gene editing, scaling, and manufacturing. Panelists will share their strategies for overcoming these hurdles, and discuss how global partnerships can expedite the transition from innovation to patient treatment.
All #ATE24 workshops are FREE to attend, simply sign up via the form below.
Date & Time: 11th September 12.45 – 13.45
This workshop focuses on simplifying cell therapy workflows for sustainability and accessibility. Explore successful scale-up strategies, innovations in manufacturing technology, and integrating scientific and business intelligence for efficient, scalable projects.
All #ATE24 workshops are FREE to attend, simply sign up via the form below.
Apply to be one of the handpicked startups and get maximum visibility at #ATE24!
Find clients, find investors, get customer feedback, build connections & tell your story at the Innovation Zone within #ATE24. Here, entrepreneurs can exhibit their cutting-edge technology, share exciting updates on their companies, and pitch to a panel of investors who’ll provide invaluable feedback to help you secure your next investment round.
The industry signals major investment opportunities arising from European biotech’s pioneering advanced therapies, rare disease treatments, and strategic acquisitions by big pharma seeking innovation pipelines. The Advanced Therapies Investment Summit offers an unparalleled opportunity to gain a competitive edge in one of biotech’s hottest sectors. This exclusive half-day summit will provide you with the strategic insights, investor perspectives, and networking opportunities to drive investment and commercialization success in the dynamic European ATMP sector.
Don’t miss this opportunity to get in on the ground floor of Europe’s biotech boom.
Navigating the European ATMP Landscape
Broad discussions surrounding the current state of the advanced therapies market in Europe, strategic roadmaps for ATMP commercialization, and the unique challenges and opportunities faced by European therapeutic developers and investors in this space.
Funding the ATMP Journey – From Seed to Commercial Success
Specific insights delving into the financing considerations for advanced therapy medicinal products (ATMPs), including assessing risk tolerance, capital expenditure, and allocation strategies across different stages of development, from early-stage funding to commercialization.
Investor Perspectives on ATMP Investment Strategies
Provides a direct platform for attendees to engage with investors actively funding ATMP companies, allowing for candid discussions and insights on investment strategies, risk assessment, and investor expectations in the rapidly evolving ATMP sector.
Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.
This site uses cookies which are essential to make the site function effectively. By using our site you accept the terms of our cookie policy. Find out more.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
